Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 588

Results For "LA"

8960 News Found

GE HealthCare expands partnership with TCS to transform IT operating model
Digitisation | July 20, 2023

GE HealthCare expands partnership with TCS to transform IT operating model

This transformation will enable GE HealthCare to build a strong foundation for business growth


Novartis acquires DTx Pharma to develop siRNA therapies
News | July 19, 2023

Novartis acquires DTx Pharma to develop siRNA therapies

Deal includes DTx-1252, a potential therapy for the neuromuscular disorder Charcot-Marie-Tooth disease type 1A (CMT1A), and two additional preclinical programs for other neuroscience indications


SEBI approves Piramal Pharma’s Rs 1,050-crore rights issue
News | July 19, 2023

SEBI approves Piramal Pharma’s Rs 1,050-crore rights issue

Piramal Pharma plans to offer fully paid-up equity shares through a rights issue to its existing eligible shareholders


Strand Life Sciences expands sequencing facility
Medical Device | July 19, 2023

Strand Life Sciences expands sequencing facility

The newly launched Genomic Health Insights (GHI) program to make sequencing accessible to all


PrecisionLife identifies first detailed genetic risk factors for long COVID
News | July 19, 2023

PrecisionLife identifies first detailed genetic risk factors for long COVID

Long COVID is a debilitating chronic condition that has affected over 100 million people globally


Evonik and Heraeus cooperate to expand the range of services for highly potent API
News | July 17, 2023

Evonik and Heraeus cooperate to expand the range of services for highly potent API

Evonik specializes in mid- to large-scale, later clinical phase HPAPIs


Granules India announces approval for Acetaminophen and Ibuprofen Tablets
Drug Approval | July 14, 2023

Granules India announces approval for Acetaminophen and Ibuprofen Tablets

This product will be launched through Granules Consumer Health (GCH) division


Lupin receives approval from USFDA for Chlorpromazine Hydrochloride Tablets USP
Drug Approval | July 14, 2023

Lupin receives approval from USFDA for Chlorpromazine Hydrochloride Tablets USP

Chlorpromazine Hydrochloride Tablets USP had an estimated annual sale of USD 45 million in the U.S.


Singapore hosts start-up immersion programme for Indian MBBS doctors
News | July 11, 2023

Singapore hosts start-up immersion programme for Indian MBBS doctors

The programme was conducted as a part of MPMCx, an exclusive management programme for MBBS doctors by IIM-Ahmedabad in collaboration with DailyRounds